Cyclosporine-associated lymphoproliferation, despite controlled cyclosporine blood concentrations, in a renal allograft recipient.

Author: DossetorJ B, KovithavongsT, PreiksaitisJ, SalkieM

Paper Details 
Original Abstract of the Article :
In a patient receiving sulfinpyrazone (Anturan, Geigy) an unusually high dose of cyclosporine (Cys) was required to maintain serum values in the range of 50-200 ng/ml. After eight months of 1300-1500 mg/day, the patient complained of increasing malaise and symptoms of cyclosporine side-effects. This...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2986094

データ提供:米国国立医学図書館(NLM)

Cyclosporine-Associated Lymphoproliferation: A Case Study

This case study, like a detailed map of a unique desert landscape, explores a rare complication associated with cyclosporine, a medication used to suppress the immune system in organ transplant recipients. The authors meticulously document the case of a patient experiencing lymphoproliferation, a condition characterized by an abnormal increase in white blood cells, despite controlled cyclosporine blood levels. Their research, like a skilled desert explorer uncovering a hidden anomaly, highlights the importance of careful monitoring and individualised treatment plans in organ transplant recipients, as unexpected complications can arise even with seemingly effective medication management.

Cyclosporine: A Complex Medication with Potential Complications

This case study serves as a reminder that even with seemingly well-controlled medications, unexpected complications can arise. Healthcare professionals must be vigilant in monitoring patients receiving immunosuppressive medications like cyclosporine, ensuring timely intervention to prevent potentially serious consequences.

Managing Organ Transplants: A Delicate Balancing Act

This research highlights the challenges of managing organ transplant recipients, requiring a delicate balance between suppressing the immune system to prevent rejection and minimizing the risk of serious side effects. Healthcare professionals must be equipped with a thorough understanding of the potential complications associated with immunosuppressive medications and be prepared to adjust treatment plans as needed.

Dr.Camel's Conclusion

This case study, like a lone palm tree in a vast desert, reminds us that even in the most carefully planned journeys, unexpected challenges can arise. Healthcare professionals must remain vigilant and adaptable, ensuring the well-being of their patients navigating the complex landscape of organ transplantation.
Date :
  1. Date Completed 1985-06-19
  2. Date Revised 2015-02-02
Further Info :

Pubmed ID

2986094

DOI: Digital Object Identifier

2986094

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.